Lv1
40 积分 2025-06-06 加入
Anti-BCMA CAR-T therapy in patients with progressive multiple sclerosis
1个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
3个月前
已完结
BCMA-CD19 armored compound CAR T cells in systemic lupus erythematosus: extended follow-up of a phase 1 clinical trial
3个月前
已完结
BCMA-CD19 armored compound CAR T cells in systemic lupus erythematosus: extended follow-up of a phase 1 clinical trial
3个月前
已完结
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
4个月前
已完结
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
4个月前
已完结
Immune reconstitution after CD7 CAR ‐T cell therapy for refractory/relapsed acute T‐lymphoblastic leukaemia/lymphoblastic lymphoma (R/R T‐ ALL / LBL )
4个月前
已完结
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
8个月前
已完结
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
8个月前
已完结
CD20CAR-T therapy preemptively treats patients with relapsed/refractory DLBCL in partial remission after CD19CAR-T
10个月前
已完结
皖公网安备34019202002308
